(Q45198841)

10 December 2017

title

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis (English)

1 reference

10 December 2017

0 references

0 references

0 references

11

1 reference

10 December 2017

Claudia L Ordoñez

1

1 reference

10 December 2017

Noreen R Henig

2

1 reference

10 December 2017

Nicole Mayer-Hamblett

3

1 reference

10 December 2017

Frank J Accurso

4

1 reference

10 December 2017

Jane L Burns

5

1 reference

10 December 2017

James F Chmiel

6

1 reference

10 December 2017

Cori L Daines

7

1 reference

10 December 2017

Ronald L Gibson

8

1 reference

10 December 2017

Sharon McNamara

9

1 reference

10 December 2017

George Z Retsch-Bogart

10

1 reference

10 December 2017

Moira L Aitken

12

1 reference

10 December 2017

language of work or name

English

0 references

publication date

11 September 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

10 December 2017

published in

1 reference

10 December 2017

volume

168

1 reference

10 December 2017

issue

12

1 reference

10 December 2017

page(s)

1471-1475

1 reference

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Safety and use of sputum induction in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Microbiology of sputum from patients at cystic fibrosis centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Early airway infection, inflammation, and lung function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Lower airway inflammation in infants and young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200306-731OC

10.1164/RCCM.200306-731OC

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference